FDA Proposes Changes to Buprenorphine Dispensing Rules for Opioid Treatment

Summary

The FDA is proposing a rule change to relax dispensing restrictions for buprenorphine and buprenorphine combination products used in opioid treatment programs, allowing for more flexibility in take-home supplies and reducing the time patients must be in treatment to receive these medications.